Moleculin Biotech announces annual shareholder meeting
MBRX•Annual meeting set for Oct. 9 in Houston
Moleculin Biotech shareholders will meet in Houston on Oct. 9, 2026 to vote on board elections and several charter changes.
The ballot includes authority for a reverse stock split at a ratio from 1-for-2 to 1-for-20.
The vote also seeks to expand the 2024 Equity Incentive Plan share pool to 4,141,894 shares from 280,010 shares.
Other items include eliminating supermajority voting requirements for charter amendments, an executive pay advisory vote, auditor ratification and adjournment authority.
